Ian Dunham: archives

The Collection contains records regarding Dr Ian Dunham's work in genomics. The majority of records related to his work on mapping and sequencing human chromosome 22, before and as part of the Human Genome Project and include: laboratory notebooks; conference papers; presentation slides; and draft publications. The Collection also contains material regarding other areas of genomic research that Dunham worked on.

There are also Sanger Institute publications including annual reports and strategic plans and there is material relating to Ian Dunham's role as writer of the Sanger Centre pantomime.

Original file titles have been retained where they exist.

1985-2007

17 boxes, 1 oversize box, 435 digital items

The files have been arranged into the following sections to best reflect how they were created and used:

Section A: Laboratory work

Section B: Conferences and meetings

Section C: Publications and talks

Section D: Newsletters

Section E: Digital correspondence

Section F: Hard drive

Donated by Dr Ian Dunham in June 2014.

Ian Dunham studied biochemistry at the University of Oxford, graduating in 1985. He continued his studies at Oxford and worked at the Medical Research Council Immunochemistry Unit, gaining his D. Phil. in 1989. He then spent a year at the Howard Hughes Medical Institute, Washington University Medical School, Department of Genetics in St Louis as a postdoctoral research associate in genetics. In 1990 he returned to Britain to the Division of Medical and Molecular Genetics at the United Medical and Dental Schools of Guy's and St Thomas' Hospitals in London and began working on a chromosome 22 project. In July 1993 he moved to the newly formed Sanger Centre (now the Wellcome Trust Sanger Institute) near Cambridge and brought this project with him, which he led. Chromosome 22 was the first human chromosome to be sequenced and was published in December 1999. Dunham remained at the Sanger Institute until 2007 when he moved to European Bioinformatics Institute (EMBL-EBI). In 2014 he was appointed scientific director of the Centre for Theraputic Target Variation (CTTV), a collaboration between GlaxoSmithKline, EMBL-EBI and the Wellcome Trust Sanger Institute.

Ian Dunham was interviewed about his work as part of the Cold Spring Harbor Laboratory oral history collection.

This collection has been catalogued and is available to library members. Some items have access restrictions which are explained in the item-level catalogue records.